RMM: In-Depth Focus 2015
Posted: 22 October 2015 | European Pharmaceutical Review
In this RMM In-Depth Focus: Implementation of a rapid methods portfolio at a pharmaceutical manufacturing site; Use of RMMs in quality control: challenges and benefits; Rapid assay for bioburden and other contaminations; RMM Roundtable…
- Implementation of a rapid methods portfolio at a pharmaceutical manufacturing site
David Roesti and Erik Wilkens, Novartis - Use of RMMs in quality control: challenges and benefits
Mostafa Eissa, Hikma Pharmaceuticals - Rapid assay for bioburden and other contaminations
Hideharu Shintani, Chuo University - Product Profile
Eurofins Lancaster Laboratories discusses its bio/pharmaceutical laboratory testing services - RMM Roundtable
Moderated by David Roesti, Senior Facilitator for RMM and Global Support, Novartis Pharma Stein AG
This RMM In-Depth Focus is restricted - login or subscribe free to access
Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.
Why subscribe? Join our growing community of thousands of industry professionals and gain access to:
- bi-monthly issues in print and/or digital format
- case studies, whitepapers, webinars and industry-leading content
- breaking news and features
- our extensive online archive of thousands of articles and years of past issues
- ...And it's all free!
Click here to Subscribe today Login here
Issue
Related topics
Related organisations
Associates of Cape Cod, Azbil BioVigilant, Charles River, Chuo University, Eurofins, Hikma Pharmaceuticals, Merck Millipore, Novartis Pharma AG, Rapid Micro Biosystems, Sartorius
